As of
(In millions)
March 29, 2019
March 30, 2018
Deferred tax assets:
Tax credit carryforwards
$54
$30
Net operating loss carryforwards of acquired companies
51
32
Other accruals and reserves not currently tax deductible
64
66
Deferred revenue
54
94
Intangible assets
384
—
Loss on investments not currently tax deductible
35
9
Stock-based compensation
87
141
Other
25
18
Gross deferred tax assets
754
390
Valuation allowance
(105)
(19)
Deferred tax assets, net of valuation allowance
$649
$371
Deferred tax liabilities:
Property and equipment
$(17)
$(5)
Goodwill
(13)
(20)
Intangible assets
—
(459)
Unremitted earnings of foreign subsidiaries
(316)
(396)
Prepaids and deferred expenses
(43)
(23)
Discount on convertible debt
(7)
(14)
Deferred tax liabilities
(396)
(917)
Net deferred tax assets (liabilities)
$253
$(546)

text: The principal components of deferred tax assets and liabilities are as follows:
text: The valuation allowance provided against our deferred tax assets as of March 29, 2019, increased primarily due to a corresponding increase in unrealized capital losses from equity investments, certain acquired tax loss and tax credits carryforwards, and California research and development credits. Based on our current operations, these attributes are not expected to be realized, and a valuation allowance has been recorded to offset them.
text: As of March 29, 2019, we have U.S. federal net operating losses attributable to various acquired companies of approximately $147 million, which, if not used, will expire between fiscal 2020 and 2037. We have U.S. federal research and development credits of approximately $11 million. The research and development credits, if not used, will expire between fiscal 2020 and 2036. $89 million of the net operating loss carryforwards and $11 million of the U.S. federal research and development tax credits are subject to limitations which currently prevent their use, and therefore these attributes are not expected to be realized. The remaining net operating loss carryforwards and U.S. federal research and development tax credits are subject to an annual limitation under U.S. federal tax regulations but are expected to be fully realized. We have $3 million of foreign tax credits which, if not used, will expire beginning in fiscal 2028. Furthermore, we have U.S. state net operating loss and credit carryforwards attributable to various acquired companies of approximately $68 million and $51 million, respectively. If not used, our U.S. state net operating losses will expire between fiscal 2020 and 2037, and the majority of our U.S. state credit carryforwards can be carried forward indefinitely. In addition, we have foreign net operating loss carryforwards attributable to various foreign companies of approximately $118 million, $24 million of which relate to Japan, and will expire beginning in fiscal 2028, and the rest of which, under current applicable foreign tax law, can be carried forward indefinitely.

Questions:
question: What does the table show?
answer: The principal components of deferred tax assets and liabilities
question: As of March 30, 2018, what is the  Tax credit carryforwards?
answer: $30
scale: million
question: What is the reason for the increase in valuation allowance provided against deferred tax assets as of March 29, 2019?
answer: due to a corresponding increase in unrealized capital losses from equity investments, certain acquired tax loss and tax credits carryforwards, and California research and development credits
question: What is the total Net deferred tax assets (liabilities) for as of  March 29, 2019 and March 30, 2018?
answer: -293
derivation: 253+(-546)
scale: million
question: What is the average Net deferred tax assets (liabilities) for as of  March 29, 2019 and  March 30, 2018?
answer: -146.5
derivation: (253+(-546))/2
scale: million
question: As of March 29, 2019, What is Intangible assets expressed as a percentage of  Gross deferred tax assets?
answer: 50.93
derivation: 384/754
scale: percent